|Page (1) of 1 - 04/16/18||email article||print page|
(April 16, 2018)
The Global Cancer Biological Therapy Market is segmented on the basis of phases. Based on the phases, the market has been segmented as phase I, phases II and phases III. Based on the type, the market has been segmented as monoclonal antibodies, interferons, interleukins, cancer growth inhibitors, gene therapy and colony-stimulating factors. Based on the end-users, the market has been segmented as hospitals & clinics, cancer research centers and laboratories.
Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. Most of the biological therapies use bacteria or vaccines to mimic the body’s immune system to act against cancer developing cells. These various types of biological therapies, which are most of the times stated to biological response modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/566 .
Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.
Global Cancer Biological Therapy Market Players:
Key players profiled in the report are Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, ELI Lilly and Company, F. Hoffmann-La Roche AG, EnGeneIC Ltd, Merck & Co., Inc., Novartis, Pfizer Inc. and others.
Cancer Biological Therapy Market Segmentation:
The Cancer Biological Therapy market has been segmented on the basis of types which comprises of monoclonal antibodies (Naked monoclonal antibodies, Conjugated monoclonal antibodies, other), interferons, interleukins, cancer growth inhibitors (Tyrosine kinase inhibitors, mTOR inhibitors and Proteasome inhibitors), gene therapy, colony-stimulating factors, targeted therapy, cancer vaccines and others.
On the basis of end user, market is segmented into hospitals & clinics, cancer research centers, laboratories and others. On the basis of Region market is segmented as US, Canada and Rest of America.
World Cancer Biological Therapy Market Regional Analysis:
Global cancer biological therapy market, on the basis of regions is divided into North America, Europe, Asia Pacific and Middle East and Africa. North America is expected to commands the largest market share due to advanced technologies are continuously on rise in these countries. Europe accounts for the second largest market, where as Asia Pacific with lots of opportunity and continuously growing economies, is expected to be the fastest growing segment. Majorly due to recent developments in healthcare and improving economies. Middle East and Africa with less economic developments and extremely low income accounts for least market share in 2016 but is expected to grow with better cancer treatment in the countries.
Major TOC for Global Cancer Biological Therapy Market Research Report- Forecast to 2023:
1 Report Prologue
2.2 Scope of Study
2.3 Research Objective
2.4 Market Structure
3 Research Process
3.1.1 Primary Research
3.1.2 Secondary Research
4 Market Dynamics
4.2.1 Increasing Cancer Survival Rate
4.2.2 Growing Demand for Advanced Therapies
4.2.3 Less Number of Side Effects as Compared to Conventional Treatment Methods
4.2.4 Growth of Cancer Healthcare Facilities in Emerging Countries
4.2.5 Changing Lifestyle and Increasing Smoking Population in Middle East & Africa
4.3.1 High cost of Cancer Biological Therapy
4.4.1 UnTapped Types of Cancers
4.5 Macroeconomic Indicators
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/566 .
LIST OF TABLES
TABLE 1 GLOBAL CANCER BIOLOGICAL THERAPY MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 2 MONOCLONAL ANTIBODIES FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION, 2014-2023 (USD MILLION)
TABLE 3 INTERFERONS FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD MILLION)
TABLE 4 INTERLEUKINS FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD MILLION)
TABLE 5 CANCER GROWTH INHIBITORS FOR CANCER BIOLOGIC THERAPY MARKET, BY REGION 2014-2023 (USD MILLION)
TABLE 6 GENE THERAPY FOR CANCER BIOLOGICAL THERAPY MARKET, BY REGION 2014-2023 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET DYNAMICS FOR GLOBAL CANCER BIOLOGICAL THERAPY MARKET
FIGURE 3 ATTRITION RATE OF PHASE III CLINICAL TRIALS IN EUROPE, 2012 (%)
FIGURE 4 CANCER BIOLOGICAL THERAPY SUCCESS RATES IN VARIOUS PHASES OF CLINICAL TRIALS
FIGURE 5 GLOBAL CANCER BIOLOGICAL THERAPY MARKET SHARE, BY TYPE 2016
FIGURE 6 GLOBAL CANCER BIOLOGICAL THERAPY MARKET SHARE, BY END USER, 2016
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research FutureContact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
Related Keywords:Business,Health & Medicine,Marketing & Sales,News & Current Affairs,Science,
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter